search
Back to results

Tolerance Study of Robotic-Assisted Virtual Reality Walking Rehabilitation for Non-Walking Stroke Patients (RAVIS)

Primary Purpose

Stroke, Central Nervous System Diseases

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
GaitTrainer and Virtual Reality
Sponsored by
University Hospital, Limoges
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke focused on measuring Stroke, Virtual Reality, Stroke Rehabilitation, Robotic, Gait Trainer

Eligibility Criteria

35 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Hemiparesis following a first ischemic or hemorrhagic stroke; subacute phase (15 days to 6 months); Aged 35 to 75 years; Non-walking subject (unable to walk 3 x 10 meters without human assistance or Functional Ambulation Classification ≤ 2); Benefiting from robot-assisted walking rehabilitation in the readaptation and physical medecin department of the Limoges University Hospital; Having the cognitive abilities to understand and follow simple verbal instructions (MMSE < 24 or BDAE < 2) Be able to give informed consent to participate in this study. Exclusion Criteria: Have neurological and psychiatric conditions, other than stroke; Conditions contraindicating the use of virtual reality (e.g., epileptic disorders, major cerebellar syndrome). Inability to evolve in a virtual environment (MSSQ-Short > 26) Patient with acute cardiovascular and respiratory disorders; Patient who is subject to a legal protection measure or who is unable to give consent; Person deprived of liberty Person with high VR experience during the 5 years before stroke pregnant woman, breastfeeding woman

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    GaitTrainer

    Arm Description

    This group of participants will benefit from 3 consecutive sessions of classic GaitTrainer without VR and then these same participants will benefit from 3 consecutive sessions of GaitTrainer with VR

    Outcomes

    Primary Outcome Measures

    CyberKinetosis
    cyberkinetosis assessed by the Simulator Sickness Questionary (SSQ). This is a 16-item questionary evaluating different symptoms on a scale from 0 (not at all) to 4 (severely).

    Secondary Outcome Measures

    Motivation to participate in immersive VR sessions
    Motivation to participate in walking rehabilitation sessions will be assessed using the Intrinsic Motivation Inventory (IMI). This is a multidimensional questionnaire used to estimate motivation to perform specific activities. The various items are evaluated on a Likert-type scale ranging from 1 to 7. The 4 subscales we'll be using are interest/pleasure, effort, usefulness and pressure/tension.
    Evaluation of the sense of presence within the Virtual environmet
    the feeling of presence in the virtual environment will be assessed by the Presence Questionnaire (PQ). It consists of 19 items designed to assess the feeling of spatial presence. Each question uses a Likert-type scale ranging from 1 to 7.
    usability of the immersive VR rehabilitation device
    The usability of the rehabilitation device will be assessed using the System Usability Scale (SUS). This is a 10-item scale giving a final score out of 100. The higher the score, the greater the perceived usability of the system.
    Assessment of walking time
    We will report the effective walking time (in minutes) during the sessions with and without the VR device.
    Assessment of number of steps
    We will report the number of steps during the sessions with and without the VR device.

    Full Information

    First Posted
    September 19, 2023
    Last Updated
    September 19, 2023
    Sponsor
    University Hospital, Limoges
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT06053619
    Brief Title
    Tolerance Study of Robotic-Assisted Virtual Reality Walking Rehabilitation for Non-Walking Stroke Patients
    Acronym
    RAVIS
    Official Title
    Tolerance Study of Robotic-Assisted Virtual Reality Walking Rehabilitation for Non-Walking Stroke Patients
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    September 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    September 20, 2023 (Anticipated)
    Primary Completion Date
    July 11, 2024 (Anticipated)
    Study Completion Date
    July 11, 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    University Hospital, Limoges

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The primary objective of this study is to evaluate the tolerance of the use of immersive virtual reality (VR) during robotic walking rehabilitation sessions by Gait Trainer (GT) in post-stroke patients. Secondary objectives aim to evaluate the motivation to participate in VR sessions compared to conventional sessions, the participants' sense of presence within the virtual environment, and the usability of the rehabilitation device created. Finally, we will report the actual walking time and number of steps stroke patients take in VR sessions and conventional sessions.
    Detailed Description
    Robotic Assisted Gait Therapy using the GT has been shown to be effective in restoring gait to non-walking stroke patients. However, GaitTrainer rehabilitation sessions can result in fatigue, sling attachment discomfort, which can limit the duration, intensity and participation of patients. Immersive Virtual Reality (VR) via visio helmet is an innovative and playful approach that allows rehabilitation to focus on specific tasks, such as walking in controlled and environmentally friendly environments. Coupled with robotic assistance, it could promote patient adherence and active participation thanks to the presence of bio-feedback and its playful aspect. However, the GT has never been associated with a walking activity simulated by a VR system. VR can lead to adverse effects (i.e., cyberkinetosis) such as dizziness, nausea or headaches. Thus, it seems necessary to observe the tolerance of the virtual environment immersion during GT assisted walking rehabilitation sessions in stroke patients. This protocol involves the recruitment of non-walking stroke participants who are being rehabilitated in a Physical Medicine and Rehabilitation (PMR) department and receiving Gait Trainer-assisted rehabilitation. The intervention will consist of Gait Trainer-assisted robotic walking rehabilitation sessions with and without the addition of an immersive VR device. Post-stroke patients will complete 3 conventional sessions (Gait Trainer alone) and 3 sessions with the VR device.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Stroke, Central Nervous System Diseases
    Keywords
    Stroke, Virtual Reality, Stroke Rehabilitation, Robotic, Gait Trainer

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    30 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    GaitTrainer
    Arm Type
    Experimental
    Arm Description
    This group of participants will benefit from 3 consecutive sessions of classic GaitTrainer without VR and then these same participants will benefit from 3 consecutive sessions of GaitTrainer with VR
    Intervention Type
    Other
    Intervention Name(s)
    GaitTrainer and Virtual Reality
    Intervention Description
    Realization of Gait Trainer-assisted robot walking rehabilitation sessions without and with the addition of an immersive VR device. The proposed virtual stage will be a natural space (i.e. forest) of 360°. The subject will be able to explore the environment without moving. The created scene represents a straight path crossing a landscape composed of different natural elements. A fluid movement is obtained with the help of two sensors (trackers) of the HTC Vive device, placed at the level of the subject's feet. Moreover, thanks to these sensors the individual has a virtual representation of his lower limbs. Post-stroke patients will perform 3 conventional sessions (Gait Trainer alone) and 3 sessions with the immersive VR device (Gait Trainer + VR).
    Primary Outcome Measure Information:
    Title
    CyberKinetosis
    Description
    cyberkinetosis assessed by the Simulator Sickness Questionary (SSQ). This is a 16-item questionary evaluating different symptoms on a scale from 0 (not at all) to 4 (severely).
    Time Frame
    2 weeks
    Secondary Outcome Measure Information:
    Title
    Motivation to participate in immersive VR sessions
    Description
    Motivation to participate in walking rehabilitation sessions will be assessed using the Intrinsic Motivation Inventory (IMI). This is a multidimensional questionnaire used to estimate motivation to perform specific activities. The various items are evaluated on a Likert-type scale ranging from 1 to 7. The 4 subscales we'll be using are interest/pleasure, effort, usefulness and pressure/tension.
    Time Frame
    2 weeks
    Title
    Evaluation of the sense of presence within the Virtual environmet
    Description
    the feeling of presence in the virtual environment will be assessed by the Presence Questionnaire (PQ). It consists of 19 items designed to assess the feeling of spatial presence. Each question uses a Likert-type scale ranging from 1 to 7.
    Time Frame
    2 weeks
    Title
    usability of the immersive VR rehabilitation device
    Description
    The usability of the rehabilitation device will be assessed using the System Usability Scale (SUS). This is a 10-item scale giving a final score out of 100. The higher the score, the greater the perceived usability of the system.
    Time Frame
    2 weeks
    Title
    Assessment of walking time
    Description
    We will report the effective walking time (in minutes) during the sessions with and without the VR device.
    Time Frame
    2 weeks
    Title
    Assessment of number of steps
    Description
    We will report the number of steps during the sessions with and without the VR device.
    Time Frame
    2 weeks

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    35 Years
    Maximum Age & Unit of Time
    75 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Hemiparesis following a first ischemic or hemorrhagic stroke; subacute phase (15 days to 6 months); Aged 35 to 75 years; Non-walking subject (unable to walk 3 x 10 meters without human assistance or Functional Ambulation Classification ≤ 2); Benefiting from robot-assisted walking rehabilitation in the readaptation and physical medecin department of the Limoges University Hospital; Having the cognitive abilities to understand and follow simple verbal instructions (MMSE < 24 or BDAE < 2) Be able to give informed consent to participate in this study. Exclusion Criteria: Have neurological and psychiatric conditions, other than stroke; Conditions contraindicating the use of virtual reality (e.g., epileptic disorders, major cerebellar syndrome). Inability to evolve in a virtual environment (MSSQ-Short > 26) Patient with acute cardiovascular and respiratory disorders; Patient who is subject to a legal protection measure or who is unable to give consent; Person deprived of liberty Person with high VR experience during the 5 years before stroke pregnant woman, breastfeeding woman
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Maxence COMPAGNAT, MD
    Email
    maxence.compagnat@chu-limoges.fr
    First Name & Middle Initial & Last Name or Official Title & Degree
    Charles MORIZIO
    Email
    charles.morizio@chu-limoges.fr

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Tolerance Study of Robotic-Assisted Virtual Reality Walking Rehabilitation for Non-Walking Stroke Patients

    We'll reach out to this number within 24 hrs